FDA
-
-
-
-
-
-
-
TFF Pharmaceuticals Reports Second Quarter Financial Results and Provides Corporate Update
-
-
-
-
-
-
-
TFF Pharmaceuticals and Leidos to Advance Next-Generation Biodefense Countermeasures Under the DARPA PPB Program into Preclinical Testing
-
-
-
-
-
-
-
TFF Pharmaceuticals (TFFP) Announces Additional Positive Data from the Tacrolimus Inhalation Powder Phase 2 Trial
-
-
-
-
-
-
-
TFF Pharmaceuticals (TFFP) Issues Update on Clinical Programs
-
-
-
-
-
-
-
TFF Pharmaceuticals to Host Webcast and Conference to Review Initial Data from the Ongoing Phase 2 Trials of TFF VORI and TFF TAC
-
-
-
-
-
-
-
TFF Pharmaceuticals Appoints Catherine Lee, J.D. to Board of Directors
-
-
-
-
-
-
-
TFF Pharmaceuticals to Participate in the H.C. Wainwright 25th Annual Global Investment Conference – September 11-13, 2023
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

